Use of eculizumab in the treatment of a case of refractory, ADAMTS13-deficient thrombotic thrombocytopenic purpura: additional data and clinical follow-up. Article uri icon

Overview

publication date

  • May 21, 2013

Research

keywords

  • Antibodies, Monoclonal, Humanized
  • Purpura, Thrombotic Thrombocytopenic

Identity

PubMed Central ID

  • PMC3720712

Scopus Document Identifier

  • 84880700770

Digital Object Identifier (DOI)

  • 10.1111/bjh.12387

PubMed ID

  • 23692124

Additional Document Info

volume

  • 162

issue

  • 4